AIS Healthcare Targeted Drug Delivery Named 2025 Pioneer in URAC’s Leaders in Performance Measurement Recognition Program
AIS Healthcare, a leading provider of targeted drug delivery and infusion care solutions, announced today that its Targeted Drug Delivery division has been recognized as a 2025 Pioneer in URAC's Leaders in Performance Measurement (LPM) recognition program. This honor is awarded to URAC-accredited organizations who demonstrate leadership in measuring and improving the quality of patient care through performance measurement.
The recognition follows URAC's annual review of performance measurement data submitted by accredited organizations, reflecting AIS Healthcare's continued commitment to evaluating and enhancing the care delivered to patients and healthcare providers.
AIS Healthcare's Targeted Drug Delivery division is focused on raising the bar for quality throughout the care continuum. From patient-specific compounded medications produced in state-of-the-art 503A compounding pharmacies, to comprehensive support services for patients and providers, AIS Healthcare goes beyond the expected to simultaneously enhance the care experience and advance quality standards at every step.
